• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Advanced NMR, GE may extend deadline

Article

Advanced NMR and GE MedicalSystems are discussing an extension of their agreement to marketfast MRI systems. The two companies may push back the deadlinefor GE to sell 100 of Advanced NMR's InstaScan echo-planar imagingsystems to Dec. 31, 1995. Under

Advanced NMR and GE MedicalSystems are discussing an extension of their agreement to marketfast MRI systems. The two companies may push back the deadlinefor GE to sell 100 of Advanced NMR's InstaScan echo-planar imagingsystems to Dec. 31, 1995.

Under the terms of an agreement reached between the companieslast year, GE gained exclusive rights to InstaScan for two yearsin return for a guarantee to buy 100 InstaScan systems or otherAdvanced NMR products by December of this year (SCAN 3/10/93).

The agreement also included an option for GE to extend thecontract, while Advanced NMR retained the right to begin adaptingits technology to non-GE systems after June of this year.

Last month, Advanced NMR announced that it has extended theexercise date from June 15 to July 31 for GE to maintain exclusiverights to InstaScan. The move gives the companies more time tonegotiate an extension of their alliance, according to AdvancedNMR. A key issue in those discussions would be an extension ofGE's deadline for sales of InstaScan to December of 1995, accordingto the company.-

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.